Silent Epidemic: 60% of High-Risk Indians Unaware of Chronic Kidney Disease, Study Finds

ANDHRA PRADESH — A silent health crisis is unfolding across India, as a groundbreaking pilot study reveals that nearly 60% of high-risk individuals in both urban and rural areas are living with Chronic Kidney Disease (CKD). Perhaps more alarming is the diagnostic vacuum: between 83% and 98% of these patients were completely unaware of their condition until they were screened as part of the research.

The study, recently published in Kidney International Reports, utilized point-of-care testing at primary health centers to screen nearly 2,000 people in the state of Andhra Pradesh. The findings have sent shockwaves through the medical community, highlighting a “silent epidemic” fueled by low public awareness, economic barriers, and significant gaps in national screening protocols. Experts are now calling for the immediate integration of kidney health checks into routine primary care to prevent a tidal wave of preventable kidney failure.

Unmasking the “Silent Killer”

Chronic Kidney Disease is often labeled a “silent killer” because it typically displays no symptoms until the kidneys are severely damaged. The pilot study focused on two distinct populations: 843 urban residents with existing non-communicable diseases (NCDs) like diabetes and hypertension in Guntur and Mangalagiri, and 1,217 rural residents from known CKD “hotspots” in Uddanam and A Konduru.

The results paint a grim picture of the nation’s renal health:

• Prevalence: CKD was detected in 57.5% of the urban high-risk group and 61.8% of the rural group.

• Awareness Gap: In urban settings, a staggering 98.6% of those diagnosed were unaware they had the disease. In rural areas, while awareness was slightly higher due to local health initiatives, 83.5% still remained in the dark.

• Disease Severity: Rural patients were more likely to be diagnosed at advanced stages. Specifically, 12.5% of rural participants were already at Stage 4, and nearly 10% had reached Stage 5 (kidney failure), compared to much lower rates in urban centers.

“Our analysis demonstrates the feasibility of using a point-of-care approach for early CKD detection,” stated lead researcher Rama Krishna Chinta in the study. “We advocate for wider implementation of CKD screening in high-risk groups and timely referral to predialysis care, which has been proven cost-effective.”

The Indian Context: A Growing Burden

India currently grapples with the world’s second-highest burden of CKD, with an estimated 138 million cases as of 2023. By 2040, medical projections suggest that number could rise significantly, with nearly 400,000 deaths annually attributed to the disease.

The drivers of this epidemic are two-fold. In urban centers, the “lifestyle trio” of diabetes, hypertension, and obesity accounts for 40-50% of cases. However, in rural hotspots like Uddanam, a mysterious form of the disease known as CKDu (Chronic Kidney Disease of unknown etiology) is prevalent. Researchers believe CKDu may be linked to environmental factors, including heat stress, pesticide exposure, or contaminated groundwater, rather than traditional risk factors.

Expert Perspectives: A Call for Policy Change

Medical professionals not involved in the study emphasize that the current national health framework is missing a critical piece of the puzzle. India’s National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD) currently mandates screening for diabetes and hypertension but does not include routine CKD testing.

Dr. Sishir Bansal, Secretary of the Indian Society of Nephrology, recently urged health officials to pivot toward prevention. “We must shift from dialysis-centric care to prevention-focused kidney health,” Dr. Bansal noted, pointing out that by the time a patient requires dialysis, the economic and physical toll is often insurmountable for the average family.

Dr. Visweswar Reddy, a Senior Consultant Nephrologist at SRM Prime Hospital, explains the urgency: “Early awareness is critical. When we catch CKD in Stages 1 or 2, we can often stop or significantly slow its progression through simple medication and lifestyle changes. Once it hits Stage 4, we are essentially managing a countdown to dialysis.”

Practical Implications: What This Means for You

For the average reader, the study serves as a vital reminder that “feeling fine” is not a guarantee of kidney health. Because the kidneys are highly adaptable, they can function relatively well even when damaged, masking the progression of the disease.

Who Should Be Screened?

Health authorities recommend annual kidney function tests (eGFR and urine albumin) for individuals who fall into the following high-risk categories:

1. Diabetics: High blood sugar can damage the millions of tiny filtering units within the kidneys.

2. Hypertensives: High blood pressure is the second leading cause of kidney failure.

3. Those over 60: Kidney function naturally declines with age.

4. Family History: Genetic predispositions play a significant role.

5. Hotspot Residents: Those living in agricultural regions with high CKD rates.

Prevention Strategies

Research suggests that early intervention can reduce the risk of progressing to kidney failure by 30-50%. Key lifestyle adjustments include:

• Blood Pressure Control: Maintaining a systolic BP of less than 120/90 mmHg.

• Sodium Reduction: Consuming less than 2,300 mg of salt per day.

• Hydration and Exercise: Aiming for 150 minutes of moderate activity weekly.

• Medication Management: Avoiding the over-use of over-the-counter painkillers (NSAIDs) like ibuprofen, which can be toxic to the kidneys over time.

Limitations and Counterarguments

While the pilot study provides a vital “snapshot,” some experts urge caution in interpreting the 60% prevalence rate as a national average. Because the study specifically targeted “high-risk” individuals, the percentage is naturally higher than what would be found in the general population (estimated at roughly 15% nationally).

Furthermore, the study utilized point-of-care eGFR testing. While efficient for mass screening, a formal diagnosis of CKD typically requires two tests taken three months apart to confirm the “chronic” nature of the decline. Critics also note that in low-resource rural settings, the cost-effectiveness of mass screening must be carefully balanced against the availability of follow-up care and specialists.

The Path Forward

The “Silent Epidemic” in Andhra Pradesh serves as a microcosm of a global challenge. As India moves toward more integrated healthcare, the message from the medical community is clear: the cost of a simple urine and blood test today is a fraction of the cost—both human and economic—of kidney failure tomorrow.

For the millions of Indians currently unaware of their risk, the transition from “silent” to “screened” could be the difference between a healthy life and a future tied to a dialysis machine.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

• https://health.economictimes.indiatimes.com/news/diagnostics/silent-epidemic-60-ckd-patients-unaware-of-their-condition-finds-study/129742950?utm_source=latest_news&utm_medium=homepage